ZD9331 as second- or third-line therapy in patients with advanced colorectal cancer: a phase II multicenter trial (Q44904011)
scientific article
Language:
Current Data About ZD9331 as second- or third-line therapy in patients with advanced colorectal cancer: a phase II multicenter trial
(P31) (Q13442814)
(P248)
(P698) 15289725
(P813) Thursday, December 7, 2017

(P304) 337-342
(P248)
(P698) 15289725
(P813) Thursday, December 7, 2017

(P407) (Q1860)

(P433) 4
(P248)
(P698) 15289725
(P813) Thursday, December 7, 2017

(P478) 27
(P248)
(P698) 15289725
(P813) Thursday, December 7, 2017

(P577) Sunday, August 1, 2004
(P248)
(P698) 15289725
(P813) Thursday, December 7, 2017

(P921) (Q42824440)

(Q188874)
(P887)

(Q6934595)
(P887)

(P1433) (Q2886177)
(P248)
(P698) 15289725
(P813) Thursday, December 7, 2017

(P1476) "ZD9331 as second- or third-line therapy in patients with advanced colorectal cancer: a phase II multicenter trial" (language: en)
(P248)
(P698) 15289725
(P813) Thursday, December 7, 2017

(P2093) Schulz J
(P1545) 1
(P248)
(P698) 15289725
(P813) Thursday, December 7, 2017

Keller A
(P1545) 2
(P248)
(P698) 15289725
(P813) Thursday, December 7, 2017

Canfield V
(P1545) 3
(P248)
(P698) 15289725
(P813) Thursday, December 7, 2017

Parker G
(P1545) 4
(P248)
(P698) 15289725
(P813) Thursday, December 7, 2017

Douglass E
(P1545) 5
(P248)
(P698) 15289725
(P813) Thursday, December 7, 2017

other details
description scientific article

External Links
(P356) 10.1097/01.COC.0000071944.01707.53
(P698) 15289725